Excipient Market Overview: Clariant sets up its first PEG excipients facility in US; India harmonizes 22 excipient monographs

DATA COMPILATION
#PharmaFlow

Pipeline Prospector March 2026 highlights: Lilly to acquire Centessa for US$ 7.8 bn; Merck buys Terns Pharma for US$ 6.7 bn

Stock Recap
#PipelineProspector

Entecavir

ACCESS ALL DATA, CHEMISTRY

ACTIVE PHARMA INGREDIENTS

46 API Suppliers, 18 USDMF, 9 CEP/COS, 11 JDMF, 1 EU WC, 13 KDMF, 10 NDC API, 24 Listed Suppliers, $ API Reference Price

DEVELOPMENTS

35 Drugs in Development

35 Drugs in Development

INTERMEDIATES

8 Intermediate Suppliers

8 Intermediate Suppliers

FINISHED DOSAGE FORMULATIONS

149 FDF Dossiers, 39 FDA Orange Book, 61 Europe, 7 Canada, 12 Australia, 2 South Africa, 28 Listed Dossiers

DRUG PRODUCT COMPOSITIONS

TABLET;ORAL - 0.5MG, TABLET;ORAL - 1MG, SOLUTION;ORAL - 0.05MG/ML

RELATED EXCIPIENT COMPANIES

2 Rochem International Inc, 17 SPI Pharma, 5 Boai NKY Pharmaceuticals Ltd, 5 Gangwal Healthcare, 6 Nanjing Well Pharmaceutical, 1 Pfanstiehl, 3 Kirsch Pharma, 1 Cerata Pharmaceuticals LLP, 4 Dr. Paul Lohmann GmbH & Co. KGaA, 1 ACG Worldwide, 7 Actylis, 1 Aeon Procare, 1 Alcedo Pharmachem, 7 Anhui Sunhere Pharmaceutical Excipients Co.,Ltd, 2 Ashland, 1 Avesta Pharma, 24 BASF, 1 CD Formulation, 2 Clariant, 10 Corel Pharma Chem, 5 DFE Pharma, 1 Esteem Industries, 1 Finar, 12 Gangwal Chemicals, 1 Gloria Interchem, 5 Ideal Cures, 4 Ingredion Pharma Solutions, 22 Kerry, 2 Keval Exports, 3 Kima Chemical, 6 Lonza Capsugel, 14 Microlex e.U, 1 Nanjing Bold Chemical, 1 Neelkanth MineChem, 2 Nitika Pharmaceutical Specialities, 2 Nomisma Healthcare, 4 Novo Excipients, 4 Pharmatrans-Sanaq, 5 Pluviaendo, 3 Prachin Chemical, 1 Qianhao Chemical (Hebei) Co., Ltd, 1 Qualicaps, 26 Roquette, 13 Seppic, 5 Shanghai Shenmei Pharmaceutical Technology Co., Ltd, 1 Shijiazhuang Huaxu Pharmaceutical, 10 Sigachi Industries, 3 Silverline Chemicals, 2 The Dow Chemical Company, 1 Ulanqab Kema New Material, 3 Vasa Pharmachem, 1 Zhejiang Huakang Pharmaceutical

EXCIPIENTS BY APPLICATIONS

72 Fillers, Diluents & Binders, 47 Coating Systems & Additives, 35 Disintegrants & Superdisintegrants, 35 Direct Compression, 32 Thickeners and Stabilizers, 27 Granulation, 26 Solubilizers, 25 Controlled & Modified Release, 21 Taste Masking, 21 Chewable & Orodispersible Aids, 20 Parenteral, 18 Topical, 16 Lubricants & Glidants, 15 Film Formers & Plasticizers, 14 Co-Processed Excipients, 9 API Stability Enhancers, 8 Emulsifying Agents, 5 Surfactant & Foaming Agents, 5 Empty Capsules, 4 Vegetarian Capsules, 4 Rheology Modifiers, 2 Coloring Agents

DIGITAL CONTENT

2 Data Compilation #PharmaFlow, 25 News #PharmaBuzz

GLOBAL SALES INFORMATION

12 US Medicaid Prescriptions, 24 Regulatory FDF Prices, 7 Annual Reports

MARKET PLACE

13 APIs, 7 FDF Dossiers

PATENTS & EXCLUSIVITIES

2 Health Canada Patents

2 Health Canada Patents

REF. STANDARDS & IMPURITIES

1 EDQM, 3 Others

ANALYTICAL

4 BioAnalytical Methods

4 BioAnalytical Methods

$ Xls download

Filters

Last Updated on PharmaCompass	Virtual Booth	Country	Registrant Name	Registration No.	Compound	Registration Date	Manufacturer	Manufacturer's Country	Manufacturer's Address
31/03/2026	Dasan Pharmaceutical	South Korea	Dasan Pharmaceutical Co., Ltd.	763-5-ND	Entecavir	2011-06-30	Dasan Pharmaceutical Co., Ltd. @ [Product Manufacturer] Shanghai Qingsong Pharmaceutical Co., Ltd	South Korea	342@No.128 Chuhua Branch Road, Fengxian Sub-part of Shanghai Chemical Industrial Park, Dogomyeon, Asan-si, Chungcheongnam-do, South Korea
31/03/2026	Dongbang FTL	South Korea	Dongbang FTL Co., Ltd.	510-2-ND	Entecavir hydrate	2010-03-31	Dongbang FTL Co., Ltd. @ Anhui Biochem Pharmaceutical Co., Ltd.	South Korea	78, Jeyakgongdan 4-gil, Hyangnam-eup, Hwaseong-si, Gyeonggi-do @ No.108 Shahe Road, Taihe, Anhui, China

Privacy policy
Terms and conditions
Disclaimers
Product listings are provided for informational purposes only. We do not supply or sell any products. Any products that may be covered by patent(s) are supplied solely for uses permitted under Section 107A of the Indian Patents Act and not for commercial sale.

Entecavir

Entecavir

ACCESS ALL DATA

CHEMISTRY

Discover Molecule Insights

ACTIVE PHARMA INGREDIENTS

46 API Suppliers

18 USDMF

9 CEP/COS

11 JDMF

1 EU WC

13 KDMF

10 NDC API

24 Listed Suppliers

$ API Reference Price

DEVELOPMENTS

35 Drugs in Development

INTERMEDIATES

8 Intermediate Suppliers

FINISHED DOSAGE FORMULATIONS

149 FDF Dossiers

39 FDA Orange Book

61 Europe

7 Canada

12 Australia

2 South Africa

28 Listed Dossiers

DRUG PRODUCT COMPOSITIONS

TABLET;ORAL - 0.5MG

TABLET;ORAL - 1MG

SOLUTION;ORAL - 0.05MG/ML

RELATED EXCIPIENT COMPANIES

2 Rochem International Inc

17 SPI Pharma

5 Boai NKY Pharmaceuticals Ltd

5 Gangwal Healthcare

6 Nanjing Well Pharmaceutical

1 Pfanstiehl

3 Kirsch Pharma

1 Cerata Pharmaceuticals LLP

4 Dr. Paul Lohmann GmbH & Co. KGaA

1 ACG Worldwide

7 Actylis

1 Aeon Procare

1 Alcedo Pharmachem

7 Anhui Sunhere Pharmaceutical Excipients Co.,Ltd

2 Ashland

1 Avesta Pharma

24 BASF

1 CD Formulation

2 Clariant

10 Corel Pharma Chem

5 DFE Pharma

1 Esteem Industries

1 Finar

12 Gangwal Chemicals

1 Gloria Interchem

5 Ideal Cures

4 Ingredion Pharma Solutions

22 Kerry

2 Keval Exports

3 Kima Chemical

6 Lonza Capsugel

14 Microlex e.U

1 Nanjing Bold Chemical

1 Neelkanth MineChem

2 Nitika Pharmaceutical Specialities

2 Nomisma Healthcare

4 Novo Excipients

4 Pharmatrans-Sanaq

5 Pluviaendo

3 Prachin Chemical

1 Qianhao Chemical (Hebei) Co., Ltd

1 Qualicaps

26 Roquette

13 Seppic

5 Shanghai Shenmei Pharmaceutical Technology Co., Ltd

1 Shijiazhuang Huaxu Pharmaceutical

10 Sigachi Industries

3 Silverline Chemicals